Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 16, 2024Open Access

A Comparative Study of MAFLD as a Predictor for Metabolic Disease Therapies Against NAFLD in Repeated Health Check-Ups: A Novel Perspective on Fatty Liver

View Full Paper
Ask AI
Bookmark
Share

Authors

JIJin ImaiSTShinji TakashimizuNSNana Suzuki

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Imai et al. (2024) studied this question.

synapsesocial.com/papers/68e78e41b6db643587700592https://doi.org/10.21203/rs.3.rs-3947258/v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparative study of MAFLD as a predictor of metabolic disease treatment for NAFLD2024 · 2 citations
  2. 2Comparison of Clinical Characteristics and Outcomes of MAFLD and NAFLD in Chinese Health Examination Populations2023 · 9 citations
  3. 3The <scp>MAFLD</scp> definition identifies three homogenous groups of patients2024 · 8 citations
  4. 4MAFLD outperforms NAFLD in identifying metabolic dysfunction in U.S. adolescents: a NHANES 2017–2020 analysis2025
  5. 5Changes in Biochemical Parameters and TheirCorrelation with Disease Severity in Patients withMetabolic Associated Fatty Liver Disease(MAFLD): A Cross-Sectional Study2026